SF68 SLIPIDÒ
Product description
Cardiovascular diseases and dyslipidemias, and alteration of gut microbiota are connected: people with high cholesterol levels have often an altered gut microbiota, qualitatively and quantitatively. Probiotics are reported to be able to reduce bloody fat levels, acting with different mechanism of action.Phytosterols are well known and widely used to reduce cholesterol levels.
Folic acid is involved on metabolism of homocysteine, alteration of which is related to an increased cardiovascular risk.
On these basis Cerbios developed its innovative Food supplement, with:
- SF68 (proprietary probiotic strain)
- phytosterols
- Methylfolate (biological active form of folic acid)
Scientific evidences: preclinical test demonstrates significant reduction of obesity and fat levels.
A clinical trial is on going to demonstrate efficacy on reduce: cholesterol, obesity and fat.
Read more
Folic acid is involved on metabolism of homocysteine, alteration of which is related to an increased cardiovascular risk.
On these basis Cerbios developed its innovative Food supplement, with:
- SF68 (proprietary probiotic strain)
- phytosterols
- Methylfolate (biological active form of folic acid)
Scientific evidences: preclinical test demonstrates significant reduction of obesity and fat levels.
A clinical trial is on going to demonstrate efficacy on reduce: cholesterol, obesity and fat.
Specifications
| Categories | Probiotics |
|---|---|
| Sales markets | Western Europe; Eastern Europe; Middle East; Asia; North America; Central/South America |
| Supplied from | Switzerland |
| Product Applications | Food Supplements; Pharmaceutical |
| Product Certifications | Health & Safety (GMP, HAACP and equivalents); Health claims |
More products from Cerbios-Pharma SA
SF68 SLIPIDÒ
